Home/Filings/4/0001209191-22-019808
4//SEC Filing

Fischesser Ryan 4

Accession 0001209191-22-019808

CIK 0001619856other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 7:14 PM ET

Size

12.0 KB

Accession

0001209191-22-019808

Insider Transaction Report

Form 4
Period: 2022-03-15
Fischesser Ryan
VP of Finance and Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-15$4.11/sh+1,138$4,677113,244 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2022-03-151,1365,679 total
    Exercise: $2.69Exp: 2029-03-18Common Stock (1,136 underlying)
  • Exercise/Conversion

    Common Stock

    2022-03-15$2.69/sh+1,136$3,056112,106 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2022-03-151,13819,314 total
    Exercise: $4.11Exp: 2031-03-29Common Stock (1,138 underlying)
Footnotes (4)
  • [F1]Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021.
  • [F2]Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share.
  • [F3]1/4th of the shares subject to this option vested on January 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. The vesting schedule for this option was inadvertently described incorrectly in the reporting person's Form 3 filed on July 23, 2021.
  • [F4]1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.

Issuer

Caribou Biosciences, Inc.

CIK 0001619856

Entity typeother

Related Parties

1
  • filerCIK 0001871155

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 7:14 PM ET
Size
12.0 KB